Y. Nakagawa et al., GASTROINTESTINAL ABSORPTION OF INSULIN-LIKE GROWTH-FACTOR IN THE MOUSE IN THE ABSENCE OF SALIVARY INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN, Biochemical pharmacology, 53(2), 1997, pp. 233-240
Based on previous observations of the presence of both insulin-like gr
owth factors I and II (IGF-I and IGF-II) in murine saliva (Kerr er al.
, Biochem Pharmacol 49: 1521-1531, 1995), the saliva from BALB/c and N
on obese diabetic (NOD) mice was examined for the presence of insulin-
like growth factor binding proteins (IGFBPs). Using a western-blot typ
e ligand binding assay with I-125-labeled IGF-I, a series of binding p
roteins with molecular masses (M(r)) between 25 and 45 kDa were detect
ed in the sera, but not saliva, from both BALB/c and diabetic NOD mice
. In the diabetic NOD mice, there were detectable changes in the conce
ntrations of several of the IGFBPs relative to BALB/c mice. Using spec
ific antibody to the binding proteins, one of these was identified as
IGFBP-2. Gavage administration of [I-125]IGF-I indicated substantial u
ptake from the gastrointestinal tract and significant tissue distribut
ion. There was an increase in serum concentrations of radiolabeled IGF
-I in diabetic NOD mice over that in BALB/c mice but less recovered fr
om most of the tissues. Intact I-125-labeled IGF-I was extracted and p
urified from various tissues, following gavage, and shown to retain bi
ological activity. Thus, the uptake of biologically active IGFs from s
aliva would appear to take place independently of specific binding pro
teins. Copyright (C) 1996 Elsevier Science Inc.